256 related articles for article (PubMed ID: 19743896)
1. Modulation of neuropeptide Y receptors for the treatment of obesity.
Sato N; Ogino Y; Mashiko S; Ando M
Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.
Félétou M; Levens NR
Curr Opin Investig Drugs; 2005 Oct; 6(10):1002-11. PubMed ID: 16259221
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
4. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
Cabrele C; Beck-Sickinger AG
J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
[TBL] [Abstract][Full Text] [Related]
6. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.
Juanenea L; Galiano S; Erviti O; Moreno A; Pérez S; Aldana I; Monge A
Bioorg Med Chem; 2004 Sep; 12(17):4717-23. PubMed ID: 15358298
[TBL] [Abstract][Full Text] [Related]
10. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
11. Role of hypothalamic neuropeptide Y in feeding and obesity.
Gehlert DR
Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
[TBL] [Abstract][Full Text] [Related]
12. Interactions between NPY and CRF in the amygdala to regulate emotionality.
Sajdyk TJ; Shekhar A; Gehlert DR
Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
Mashiko S; Moriya R; Ishihara A; Gomori A; Matsushita H; Egashira S; Iwaasa H; Takahashi T; Haga Y; Fukami T; Kanatani A
Eur J Pharmacol; 2009 Aug; 615(1-3):113-7. PubMed ID: 19482021
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
16. NPY and Y receptors: lessons from transgenic and knockout models.
Lin S; Boey D; Herzog H
Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
[TBL] [Abstract][Full Text] [Related]
17. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
18. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
20. Molecular evolution of NPY receptor subtypes.
Larhammar D; Salaneck E
Neuropeptides; 2004 Aug; 38(4):141-51. PubMed ID: 15337367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
